Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Int J Cancer
    May 2024
  1. HUI Z, Wang B, Liu Z, Wei J, et al
    TGFbeta-induced EN1 promotes tumor budding of adenoid cystic carcinoma in patient-derived organoid model.
    Int J Cancer. 2024;154:1814-1827.
    >> Share

  2. FANG F, Ritz B, Rao J, Zhu Y, et al
    Association between ambient exposure to PM(2.5) and upper aerodigestive tract cancer in Los Angeles.
    Int J Cancer. 2024;154:1579-1586.
    >> Share

    April 2024
  3. BUDUKH A, Dora T, Sancheti S, Singh V, et al
    Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India.
    Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966.
    >> Share

  4. NAKAGAWA T, Santos J, Nasamran CA, Sen P, et al
    Defining the relationship of salivary gland malignancies to novel cell subpopulations in human salivary glands using single nucleus RNA-sequencing.
    Int J Cancer. 2024;154:1492-1503.
    >> Share

  5. DI W, Yu J, Zong D, Ge Y, et al
    Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China.
    Int J Cancer. 2024 Apr 10. doi: 10.1002/ijc.34933.
    >> Share

  6. LEE JH, Ming Z, Cheung VKY, Pedersen B, et al
    Ex vivo tissue modelling informs drug selection for rare cancers.
    Int J Cancer. 2024;154:1158-1163.
    >> Share

    March 2024
  7. CHARTERS E, Cheng K, Dunn M, Heng C, et al
    Restorabite: Phase II trial of jaw stretching exercises using a novel device for patients with trismus following head and neck cancer.
    Int J Cancer. 2024 Mar 31. doi: 10.1002/ijc.34941.
    >> Share

  8. MADRIGAL JM, Troisi R, Surcel HM, Ohman H, et al
    Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
    Int J Cancer. 2024;154:979-991.
    >> Share

  9. LU Y, Clifford GM, Fairley CK, Grulich AE, et al
    Human papillomavirus and p16(INK4a) in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2024;154:830-841.
    >> Share

    February 2024
  10. RINALDI S, Dossus L, Keski-Rahkonen P, Kiss A, et al
    Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
    Int J Cancer. 2024 Feb 15. doi: 10.1002/ijc.34872.
    >> Share

  11. SEYYEDSALEHI MS, Boffetta P
    Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Feb 10. doi: 10.1002/ijc.34881.
    >> Share

  12. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
    Int J Cancer. 2024 Feb 5. doi: 10.1002/ijc.34861.
    >> Share

    January 2024
  13. KAIMILA B, Yano Y, Mulima G, Chen Y, et al
    Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi.
    Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34829.
    >> Share

    November 2023
  14. STUART CM, Meguid RA, Bronsert MR, Rodriguez Franco S, et al
    The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study.
    Int J Cancer. 2023 Nov 28. doi: 10.1002/ijc.34805.
    >> Share


  15. Correction to "A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers".
    Int J Cancer. 2023 Nov 19. doi: 10.1002/ijc.34789.
    >> Share

  16. RANGEL-POZZO A, Dos Santos FF, Dettori T, Giulietti M, et al
    Three-dimensional nuclear architecture distinguishes thyroid cancer histotypes.
    Int J Cancer. 2023;153:1842-1853.
    >> Share

    October 2023
  17. DOCHI H, Kondo S, Komura S, Moriyama-Kita M, et al
    Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
    Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34777.
    >> Share

    September 2023
  18. RAN X, Zeng H, Zheng R, Sun K, et al
    Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population-based study.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34730.
    >> Share

  19. LEHTINEN M, Butt J, Gray P, Brenner N, et al
    HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study.
    Int J Cancer. 2023;153:1313-1315.
    >> Share

  20. SCOBIOALA S, Parfitt R, Matulat P, Byrne J, et al
    The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34732.
    >> Share

  21. KUSTERS JMA, Diergaarde B, Ness A, Schim van der Loeff MF, et al
    Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
    Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34710.
    >> Share

    August 2023
  22. PIERSIALA K, Hjalmarsson E, da Silva PFN, Lagebro V, et al
    Regulatory B cells producing IL-10 are increased in human tumor draining lymph nodes.
    Int J Cancer. 2023;153:854-866.
    >> Share

    July 2023
  23. GOETZE TO, Hofheinz RD, Gaiser T, Schmalenberg H, et al
    Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
    Int J Cancer. 2023;153:153-163.
    >> Share

    June 2023
  24. SEO S, Keam B, Shin SH, Chae YS, et al
    A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer.
    Int J Cancer. 2023 Jun 26. doi: 10.1002/ijc.34622.
    >> Share

  25. ISHIHARA M, Nishida Y, Kitano S, Kawai A, et al
    A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma.
    Int J Cancer. 2023;152:2554-2566.
    >> Share

    May 2023
  26. ZHENG XH, Deng CM, Zhou T, Li XZ, et al
    Saliva biopsy: Detecting the difference of EBV DNA methylation in the diagnosis of nasopharyngeal carcinoma.
    Int J Cancer. 2023 May 12. doi: 10.1002/ijc.34561.
    >> Share

  27. ZHU H, Yip HC, Cheung MK, Chan HC, et al
    Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma.
    Int J Cancer. 2023;152:1903-1915.
    >> Share

    April 2023
  28. DEMIN DE, Murashko MM, Uvarova AN, Stasevich EM, et al
    Adversary of DNA integrity: A long non-coding RNA stimulates driver oncogenic chromosomal rearrangement in human thyroid cells.
    Int J Cancer. 2023;152:1452-1462.
    >> Share

    March 2023
  29. DU Y, Feng R, Chang ET, Yin L, et al
    Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: a population-based patient cohort study in southern China.
    Int J Cancer. 2023 Mar 25. doi: 10.1002/ijc.34524.
    >> Share

  30. ZHU X, Heng Y, Zhou J, Lin H, et al
    Time-varying association of Second Primary Malignancy and Long-term Survival Outcomes in Patients with Head and Neck Cancer.
    Int J Cancer. 2023 Mar 22. doi: 10.1002/ijc.34520.
    >> Share

  31. GHASEMI-KEBRIA F, Semnani S, Fazel A, Etemadi A, et al
    Esophageal and gastric cancer incidence trends in Golestan, Iran: an age-period-cohort analysis 2004-2018.
    Int J Cancer. 2023 Mar 21. doi: 10.1002/ijc.34518.
    >> Share

  32. KUIJPER SC, Pape M, Haj Mohammad N, van Voorthuizen T, et al
    SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy.
    Int J Cancer. 2023;152:1202-1209.
    >> Share

  33. MOHRING C, Manczak A, Timotheou A, Sadeghlar F, et al
    Perioperative Therapy with Flot4 Significantly Increases Survival in Patients with Gastroesophageal and Gastric Cancer in A Large Real-World Cohort.
    Int J Cancer. 2023 Mar 15. doi: 10.1002/ijc.34511.
    >> Share

  34. NGUYEN HT, Tang W, Webster ALH, Whiteaker JR, et al
    Fanconi anemia-isogenic head and neck cancer cell line pairs - a basic and translational science resource.
    Int J Cancer. 2023 Mar 13. doi: 10.1002/ijc.34506.
    >> Share

  35. ZHENG XH, Li XZ, Zhou T, Jiang CT, et al
    Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.
    Int J Cancer. 2023 Mar 6. doi: 10.1002/ijc.34491.
    >> Share

  36. KUIJPER SC, Pape M, Vissers PAJ, Jeene PM, et al
    Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Mar 1. doi: 10.1002/ijc.34488.
    >> Share

    February 2023
  37. PAPE M, Kuijper SC, Vissers PAJ, Ruurda JP, et al
    Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Feb 25. doi: 10.1002/ijc.34480.
    >> Share

  38. LIU T, Bai Y, Lin X, Li W, et al
    First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis.
    Int J Cancer. 2023;152:749-760.
    >> Share

  39. SIMBA H, Menya D, Mmbaga BT, Dzamalala C, et al
    The contribution of smoking and smokeless tobacco to esophageal squamous cell carcinoma risk in the African esophageal cancer corridor: results from the ESCCAPE multicenter case-control studies.
    Int J Cancer. 2023 Feb 2. doi: 10.1002/ijc.34458.
    >> Share

    January 2023
  40. BUDHATHOKI S, Diergaarde B, Liu G, Olshan A, et al
    A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers.
    Int J Cancer. 2023 Jan 24. doi: 10.1002/ijc.34444.
    >> Share

  41. SUZUKI H
    HPV hijacks enhancers to activate oncogenes in head and neck squamous cell carcinoma cells.
    Int J Cancer. 2023 Jan 24. doi: 10.1002/ijc.34440.
    >> Share

  42. MIMA M, Okabe A, Hoshii T, Nakagawa T, et al
    Tumorigenic activation around HPV integrated sites in head and neck squamous cell carcinoma.
    Int J Cancer. 2023 Jan 17. doi: 10.1002/ijc.34439.
    >> Share

  43. CARVAJAL LJ, Shing JZ, Vanegas JC, Gonzalez E, et al
    TRENDS IN INCIDENCE RATES OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS OVERALL AND BY POTENTIAL RELATEDNESS TO HUMAN PAPILLOMAVIRUS, COSTA RICA 2006-2015.
    Int J Cancer. 2023 Jan 17. doi: 10.1002/ijc.34437.
    >> Share

    December 2022
  44. BOERNER T, Carr RA, Hsu M, Michel A, et al
    Incidence and Management of Esophageal Cancer Recurrence to Regional Lymph Nodes After Curative Esophagectomy.
    Int J Cancer. 2022 Dec 27. doi: 10.1002/ijc.34417.
    >> Share

  45. JIN Z, Pei S, Ouyang L, Zhang L, et al
    Thy-Wise: An interpretable machine learning model for the evaluation of thyroid nodules.
    Int J Cancer. 2022;151:2229-2243.
    >> Share

    November 2022
  46. HAO Y, Karaoz U, Yang L, Yachimski PS, et al
    Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett's esophagus and esophageal adenocarcinoma.
    Int J Cancer. 2022;151:1703-1716.
    >> Share

  47. YANG H, Wang XK, Wang JB, Zhao FH, et al
    Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population.
    Int J Cancer. 2022;151:1462-1473.
    >> Share

    October 2022
  48. HERMUS M, van der Wilk BJ, Chang RTH, Collee G, et al
    Patient preferences for active surveillance versus standard surgery after neoadjuvant chemoradiotherapy in esophageal cancer treatment: the NOSANO-study.
    Int J Cancer. 2022 Oct 17. doi: 10.1002/ijc.34327.
    >> Share

  49. WANG Q, Xie H, Li Y, Theodoropoulos N, et al
    Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans.
    Int J Cancer. 2022;151:1291-1303.
    >> Share

  50. SOROUSH A, Malekzadeh R, Roshandel G, Khoshnia M, et al
    Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34313.
    >> Share

  51. MA Y, Li W, Chen S, Lin S, et al
    Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34315.
    >> Share

    September 2022
  52. ZHU H, Ma X, Ye T, Wang H, et al
    Esophageal cancer in China: practice and research in the new era.
    Int J Cancer. 2022 Sep 24. doi: 10.1002/ijc.34301.
    >> Share

  53. POELL JB, Wils LJ, Brink A, Dietrich R, et al
    Oral cancer prediction by noninvasive genetic screening.
    Int J Cancer. 2022 Sep 7. doi: 10.1002/ijc.34277.
    >> Share

    August 2022
  54. GHOLAP D, Dikshit R, Chaturvedi P, Chaturvedi AK, et al
    Exclusive use of different types of tobacco products, exposure to second hand tobacco smoke and risk of subtypes of head and neck cancer among Indian males.
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34258.
    >> Share

  55. LIU Y, Zheng Z, Li M, Zhang Y, et al
    Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
    Int J Cancer. 2022;151:607-615.
    >> Share

  56. TIAN Y, Tang C, Shi G, Wang G, et al
    Novel fluorescent GLUT1 inhibitor for precision detection and fluorescence image-guided surgery in oral squamous cell carcinoma.
    Int J Cancer. 2022;151:450-462.
    >> Share

  57. AN L, Zheng R, Zeng H, Zhang S, et al
    The survival of esophageal cancer by subtype in China with comparison to the United States.
    Int J Cancer. 2022 Aug 1. doi: 10.1002/ijc.34232.
    >> Share

    July 2022
  58. NOMBURG J, Bullman S, Nasrollahzadeh D, Collisson EA, et al
    An international report on bacterial communities in esophageal squamous cell carcinoma.
    Int J Cancer. 2022 Jul 15. doi: 10.1002/ijc.34212.
    >> Share

    June 2022
  59. WANG S, Zheng R, Arnold M, Abnet C, et al
    Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34158.
    >> Share

    May 2022
  60. IM PK, Yang L, Kartsonaki C, Chen Y, et al
    Alcohol metabolism genes and risks of site-specific cancers in Chinese adults: An 11-year prospective study.
    Int J Cancer. 2022;150:1627-1639.
    >> Share

    April 2022
  61. COLLATUZZO G, Etemadi A, Sotoudeh M, Nikmanesh A, et al
    Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran.
    Int J Cancer. 2022 Apr 30. doi: 10.1002/ijc.34056.
    >> Share

  62. LAAKSONEN MA, MacInnis RJ, Canfell K, Shaw JE, et al
    Thyroid cancers potentially preventable by reducing overweight and obesity in Australia: A pooled cohort study.
    Int J Cancer. 2022;150:1281-1290.
    >> Share

  63. LIU H, Li G, Sturgis EM, Shete S, et al
    Genetic variants in CYP2B6 and HSD17B12 associated with the risk of squamous cell carcinoma of the head and neck.
    Int J Cancer. 2022 Apr 11. doi: 10.1002/ijc.34023.
    >> Share

  64. GARSET-ZAMANI M, Carlander AF, Jakobsen KK, Friborg J, et al
    Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Int J Cancer. 2022;150:1174-1183.
    >> Share

    March 2022
  65. LONG Z, Wang W, Liu W, Wang F, et al
    Trend of nasopharyngeal carcinoma mortality and years of life lost in China and Its Provinces from 2005 to 2020.
    Int J Cancer. 2022 Mar 14. doi: 10.1002/ijc.33998.
    >> Share

  66. RETTIG EM, Faden DL, Sandhu S, Wong K, et al
    Detection of Circulating Tumor Human Papillomavirus DNA Before Diagnosis of HPV-Positive Head and Neck Cancer.
    Int J Cancer. 2022 Mar 9. doi: 10.1002/ijc.33996.
    >> Share

    February 2022
  67. ANTONSSON A, de Souza MMA, Panizza BJ, Whiteman DC, et al
    Sexual debut and association with oral HPV infection, persistence and oropharyngeal cancer - an analysis of two Australian cohorts.
    Int J Cancer. 2022 Feb 28. doi: 10.1002/ijc.33986.
    >> Share

  68. LIU J, Li J, Lin W, Shao D, et al
    Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study.
    Int J Cancer. 2022 Feb 21. doi: 10.1002/ijc.33976.
    >> Share

  69. WURSTHORN A, Schwager C, Kurth I, Peitzsch C, et al
    High-Complexity cellular barcoding and clonal tracing reveals stochastic and deterministic parameters of radiation resistance.
    Int J Cancer. 2022;150:663-677.
    >> Share

  70. PATEL KK, Chakravarti P, Chaturvedi P, Dikshit R, et al
    The fifth round of the National Family Health Survey of India 2019 to 2021 reported low screening uptake alarming to strengthen the implementation of early detection services of the cervix, breast and oral cancer.
    Int J Cancer. 2022 Feb 6. doi: 10.1002/ijc.33958.
    >> Share

  71. LIU X, Liu P, Chernock RD, Lang Kuhs KA, et al
    Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2022;150:521-531.
    >> Share

  72. DE VEGT F, Gommers JJJ, Groenewoud H, Siersema PD, et al
    Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041.
    Int J Cancer. 2022;150:420-430.
    >> Share

  73. GHANTOUS Y, Omar M, Broner EC, Agrawal N, et al
    A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma.
    Int J Cancer. 2022;150:450-460.
    >> Share

    January 2022
  74. VAN DER WATT PJ, Okpara MO, Wishart A, Parker MI, et al
    Nuclear transport proteins are secreted by cancer cells and identified as potential novel cancer biomarkers.
    Int J Cancer. 2022;150:347-361.
    >> Share

  75. GAO P, Cai N, Yang X, Yuan Z, et al
    Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China.
    Int J Cancer. 2022;150:243-252.
    >> Share

  76. KRENS SD, van Boxtel W, Uijen MJM, Jansman FGA, et al
    Exposure-toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer.
    Int J Cancer. 2022;150:308-316.
    >> Share

    December 2021
  77. DENEUVE S, Perol O, Dantony E, Guizard AV, et al
    Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France.
    Int J Cancer. 2021 Dec 10. doi: 10.1002/ijc.33896.
    >> Share

    November 2021
  78. LASSEN P, Huang SH, Su J, Waldron J, et al
    Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
    Int J Cancer. 2021 Nov 18. doi: 10.1002/ijc.33876.
    >> Share

    October 2021
  79. TAWK B, Wirkner U, Schwager C, Rein K, et al
    Tumor DNA-Methylome derived Epigenetic Fingerprint Identifies HPV-negative Head and Neck Patients at Risk for Locoregional Recurrence after Postoperative Radiochemotherapy.
    Int J Cancer. 2021 Oct 14. doi: 10.1002/ijc.33842.
    >> Share

    September 2021
  80. DE LA COUR CD, von Buchwald C, Dehlendorff C, Garset-Zamani M, et al
    Low-dose aspirin use and mortality risk in patients with head and neck cancer - a nationwide cohort study of 10,770 patients.
    Int J Cancer. 2021 Sep 18. doi: 10.1002/ijc.33814.
    >> Share

  81. CABASAG CJ, Arnold M, Pineros M, Morgan E, et al
    Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
    Int J Cancer. 2021;149:1239-1246.
    >> Share

  82. TANAKA H, Suzuki M, Takemoto N, Fukusumi T, et al
    Performance of Oral HPV DNA, Oral HPV mRNA, and Circulating Tumor HPV DNA in the Detection of HPV-Related Oropharyngeal Cancer and Cancer of Unknown Primary.
    Int J Cancer. 2021 Sep 6. doi: 10.1002/ijc.33798.
    >> Share

  83. NABHAN F, Dedhia PH, Ringel MD
    Thyroid cancer, recent advances in diagnosis and therapy.
    Int J Cancer. 2021;149:984-992.
    >> Share

    July 2021
  84. NAUTA IH, Heideman DAM, Brink A, van der Steen B, et al
    The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma.
    Int J Cancer. 2021;149:420-430.
    >> Share

    June 2021
  85. BUDUKH A, Dikshit R, Chaturvedi P
    Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID-19 pandemic situation.
    Int J Cancer. 2021 Jun 21. doi: 10.1002/ijc.33712.
    >> Share

  86. TRUONG T, Lesueur F, Sugier PE, Guibon J, et al
    Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
    Int J Cancer. 2021;148:2935-2946.
    >> Share

    May 2021
  87. HOFHEINZ RD, Hegewisch-Becker S, Kunzmann V, Thuss-Patience P, et al
    Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study G
    Int J Cancer. 2021 May 21. doi: 10.1002/ijc.33696.
    >> Share

  88. NARH CT, Dzamalala CP, Mmbaga BT, Menya D, et al
    Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor - Findings from the ESCCAPE multi-country case-control studies.
    Int J Cancer. 2021 May 18. doi: 10.1002/ijc.33688.
    >> Share

    April 2021
  89. BUSSMANN L, Hoffer K, von Bargen CM, Droste C, et al
    Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets.
    Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33606.
    >> Share

  90. SHI Z, Wei J, Na R, Resurreccion WK, et al
    Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
    Int J Cancer. 2021;148:1658-1664.
    >> Share

  91. LING Z, Cheng B, Tao X
    Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities.
    Int J Cancer. 2021;148:1548-1561.
    >> Share

    March 2021
  92. MIDDLETON DRS, Mmbaga BT, O'Donovan M, Abedi-Ardekani B, et al
    Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting.
    Int J Cancer. 2021;148:1208-1218.
    >> Share

  93. IMAMURA Y, Toihata T, Haraguchi I, Ogata Y, et al
    Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
    Int J Cancer. 2021;148:1260-1275.
    >> Share

  94. LIU Y, Lai F, Long J, Peng S, et al
    Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases.
    Int J Cancer. 2021;148:1106-1114.
    >> Share

    February 2021
  95. PARAD MT, Fararouei M, Mirahmadizadeh AR, Afrashteh S, et al
    Thyroid cancer and its associated factors: a population based case-control study.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33537.
    >> Share

  96. XIE SH, Ness-Jensen E, Langseth H, Gislefoss RE, et al
    Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma.
    Int J Cancer. 2021;148:905-913.
    >> Share

    January 2021
  97. TAKADA K, Aizawa Y, Sano D, Okuda R, et al
    Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
    Int J Cancer. 2021;148:193-202.
    >> Share

    December 2020
  98. CHOI J, Jia G, Wen W, Long J, et al
    Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
    Int J Cancer. 2020;147:3416-3423.
    >> Share

  99. ANTONSSON A, de Souza M, Wood ZC, Carroll A, et al
    Natural history of oral HPV infection - longitudinal analyses in prospective cohorts from Australia.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33442.
    >> Share

    November 2020
  100. SONG L, Zhang S, Yu S, Ma F, et al
    Cellular heterogeneity landscape in laryngeal squamous cell carcinoma.
    Int J Cancer. 2020;147:2879-2890.
    >> Share

  101. CAPPAGLI V, Caldarella A, Manneschi G, Piaggi P, et al
    Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
    Int J Cancer. 2020;147:2838-2846.
    >> Share

  102. GARCIA RODRIGUEZ LA, Soriano-Gabarro M, Vora P, Cea Soriano L, et al
    Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
    Int J Cancer. 2020;147:2394-2404.
    >> Share

  103. JUWEID ME, Tulchinsky M, Mismar A, Momani M, et al
    Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
    Int J Cancer. 2020;147:2345-2354.
    >> Share

    October 2020
  104. BASILI T, Dopeso H, Kim SH, Ferrando L, et al
    Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.
    Int J Cancer. 2020;147:2253-2264.
    >> Share

  105. YUAN S, Kar S, Vithayathil M, Carter P, et al
    Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two-sample Mendelian randomization study.
    Int J Cancer. 2020;147:1895-1903.
    >> Share

    September 2020
  106. SIRRI E, Kieschke J, Vohmann C, Katalinic A, et al
    Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.
    Int J Cancer. 2020;147:1548-1558.
    >> Share

    August 2020
  107. BOSETTI C, Carioli G, Santucci C, Bertuccio P, et al
    Global trends in oral and pharyngeal cancer incidence and mortality.
    Int J Cancer. 2020;147:1040-1049.
    >> Share

    May 2020
  108. MESSERSCHMIDT C, Obermayer B, Klinghammer K, Ochsenreither S, et al
    Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
    Int J Cancer. 2020 May 29. doi: 10.1002/ijc.33123.
    >> Share

    November 2019
  109. VEYER D, Wack M, Mandavit M, Garrigou S, et al
    HPV circulating tumoral DNA quantification by droplet-based digital PCR: a promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Int J Cancer. 2019 Nov 22. doi: 10.1002/ijc.32804.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016